GlaxoSmithKline Pharmaceuticals Limited
Held by 135 mutual fund schemes, ₹2,571Cr between them.
The largest single position is SBI Midcap Fund (SBI), which holds 1.3% of its portfolio in GlaxoSmithKline Pharmaceuticals Limited — ₹320.25Cr, or 12.5% of all the mutual fund money in this stock.
The five largest holders account for 49% of it, across 135 schemes in total.
15 of the 60 largest holdings sit in sectoral/ thematic funds, the most of any category here.
Funds holding GlaxoSmithKline Pharmaceuticals Limited
135Largest rupee position first, top 60 shown. One row per scheme — a fund’s Direct and Regular plans hold the same portfolio, so the Direct plan stands for both.
| Fund | Category | Weight | Position | Fund size |
|---|---|---|---|---|
| SBI Midcap Fund | Mid Cap Fund | 1.32% | ₹320.25Cr | ₹24,262Cr |
| Kotak Large & Mid Cap Fund | Large & Mid Cap Fund | 0.89% | ₹283.83Cr | ₹31,891Cr |
| Nippon India Pharma Fund | Sectoral/ Thematic | 2.83% | ₹262.39Cr | ₹9,272Cr |
| Quant Mid Cap Fund | Mid Cap Fund | 2.97% | ₹238.04Cr | ₹8,023Cr |
| Nippon India Growth Mid Cap Fund | Mid Cap Fund | 0.29% | ₹148.31Cr | ₹51,142Cr |
| SBI Dividend Yield Fund | Dividend Yield Fund | 1.44% | ₹122.22Cr | ₹8,488Cr |
| Bandhan Large & Mid Cap Fund | Large & Mid Cap Fund | 0.42% | ₹85.23Cr | ₹20,292Cr |
| Bajaj Finserv Flexi Cap Fund | Flexi Cap Fund | 0.92% | ₹76.84Cr | ₹8,353Cr |
| BANDHAN ELSS - Tax Saver Fund | ELSS | 1.04% | ₹71.87Cr | ₹6,911Cr |
| Mahindra Manulife Small Cap Fund | Small Cap Fund | 1.13% | ₹59.35Cr | ₹5,252Cr |
| Nippon India Multi Cap Fund | Multi Cap Fund | 0.09% | ₹50.01Cr | ₹55,566Cr |
| Tata Aggressive Hybrid Fund | Aggressive Hybrid Fund | 1.56% | ₹48.82Cr | ₹3,130Cr |
| Quant ELSS Tax Saver Fund | ELSS | 0.34% | ₹45.70Cr | ₹13,377Cr |
| Aditya Birla Sun Life MNC Fund | Sectoral/ Thematic | 1.30% | ₹42.32Cr | ₹3,252Cr |
| Baroda BNP Paribas Mid Cap Fund | Mid Cap Fund | 1.56% | ₹40.51Cr | ₹2,597Cr |
| Tata Business Cycle Fund | Sectoral/ Thematic | 1.46% | ₹38.01Cr | ₹2,604Cr |
| quant Healthcare Fund | Sectoral/ Thematic | 8.89% | ₹36.61Cr | ₹411.56Cr |
| Helios Mid Cap Fund | Mid Cap Fund | 1.73% | ₹36.44Cr | ₹2,106Cr |
| Bajaj Finserv Multi Cap Fund | Multi Cap Fund | 2.25% | ₹35.27Cr | ₹1,568Cr |
| Bandhan Multi Cap Fund | Multi Cap Fund | 1.04% | ₹31.69Cr | ₹3,047Cr |
| Bajaj Finserv Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 2.17% | ₹27.26Cr | ₹1,256Cr |
| Aditya Birla Sun Life Multi-Cap Fund | Multi Cap Fund | 0.35% | ₹25.77Cr | ₹7,306Cr |
| Kotak Manufacture in India Fund | Sectoral/ Thematic | 0.84% | ₹25.43Cr | ₹3,027Cr |
| Quant Multi Cap Fund | Multi Cap Fund | 0.32% | ₹24.82Cr | ₹7,721Cr |
| Bajaj Finserv Large & Mid Cap Fund | Large & Mid Cap Fund | 0.97% | ₹23.55Cr | ₹2,427Cr |
| quant Dynamic Asset Allocation Fund | Dynamic Asset Allocation or Balanced Advantage | 2.61% | ₹22.62Cr | ₹865.62Cr |
| Bandhan Multi Asset Allocation Fund | Multi Asset Allocation | 0.54% | ₹19.82Cr | ₹3,670Cr |
| Bajaj Finserv Multi Asset Allocation Fund | Multi Asset Allocation | 0.92% | ₹17.94Cr | ₹1,950Cr |
| Helios Small Cap Fund | Small Cap Fund | 1.08% | ₹17.36Cr | ₹1,607Cr |
| Helios Large & Mid Cap Fund | Large & Mid Cap Fund | 1.21% | ₹17.28Cr | ₹1,428Cr |
| Baroda BNP Paribas Dividend Yield Fund | Dividend Yield Fund | 2.83% | ₹16.57Cr | ₹585.48Cr |
| Union Flexi Cap Fund | Flexi Cap Fund | 0.66% | ₹15.87Cr | ₹2,404Cr |
| DSP Quant Fund | Sectoral/ Thematic | 1.88% | ₹14.28Cr | ₹759.72Cr |
| SBI Quant Fund | Sectoral/ Thematic | 0.48% | ₹13.97Cr | ₹2,910Cr |
| Kotak ESG Exclusionary Strategy Fund | Sectoral/ Thematic | 1.66% | ₹12.26Cr | ₹738.60Cr |
| ITI Mid Cap Fund | Mid Cap Fund | 0.80% | ₹11.95Cr | ₹1,494Cr |
| Tata Retirement Savings Fund-Progressive | Retirement Fund | 0.52% | ₹11.50Cr | ₹2,211Cr |
| Tata India Pharma & Healthcare Fund | Sectoral/ Thematic | 0.69% | ₹10.59Cr | ₹1,534Cr |
| Tata Retirement Savings Fund-Moderate | Retirement Fund | 0.47% | ₹10.40Cr | ₹2,212Cr |
| Nippon India ETF Nifty Midcap 150 | Other ETFs | 0.27% | ₹10.40Cr | ₹3,850Cr |
| Motilal Oswal Nifty Midcap 150 Index Fund | Index Funds | 0.26% | ₹10.39Cr | ₹3,995Cr |
| DSP Nifty Midcap 150 Quality 50 Index Fund | Index Funds | 2.35% | ₹10.03Cr | ₹426.87Cr |
| Bandhan Healthcare Fund | Sectoral/ Thematic | 3.07% | ₹9.98Cr | ₹324.95Cr |
| Mahindra Manulife ELSS Tax Saver Fund | ELSS | 0.91% | ₹8.08Cr | ₹887.63Cr |
| Nippon India Nifty Midcap 150 Index Fund | Index Funds | 0.27% | ₹7.43Cr | ₹2,752Cr |
| UTI Nifty Midcap 150 Quality 50 Index Fund | Index Funds | 2.35% | ₹5.94Cr | ₹252.71Cr |
| Aditya Birla Sun Life Pharma and Healthcare Fund | Sectoral/ Thematic | 0.53% | ₹5.58Cr | ₹1,063Cr |
| Union Multi Asset Allocation Fund | Multi Asset Allocation | 0.55% | ₹5.52Cr | ₹1,004Cr |
| Bajaj Finserv Healthcare Fund | Sectoral/ Thematic | 1.42% | ₹5.52Cr | ₹388.57Cr |
| Bandhan Flexi Cap Fund | Flexi Cap Fund | 0.07% | ₹5.23Cr | ₹7,472Cr |
| Union Aggressive Hybrid Fund | Aggressive Hybrid Fund | 0.65% | ₹4.91Cr | ₹755.96Cr |
| Mirae Asset Nifty Midcap 150 ETF | Equity ETF | 0.26% | ₹4.88Cr | ₹1,848Cr |
| Union Balanced Advantage Fund | Dynamic Asset Allocation or Balanced Advantage | 0.33% | ₹4.03Cr | ₹1,222Cr |
| Baroda BNP Paribas Health and Wellness Fund | Sectoral/ Thematic | 0.78% | ₹3.98Cr | ₹509.83Cr |
| The Wealth Company Flexi Cap Fund | Flexi Cap Fund | 1.53% | ₹3.78Cr | ₹246.73Cr |
| Baroda BNP Paribas Services Fund | Sectoral/ Thematic | 0.88% | ₹3.44Cr | ₹390.74Cr |
| ICICI Prudential Nifty Midcap 150 Index Fund | Index Funds | 0.26% | ₹3.39Cr | ₹1,281Cr |
| Tata Nifty MidSmall Healthcare Index Fund | Index Funds | 1.56% | ₹3.28Cr | ₹210.49Cr |
| SBI Nifty Midcap 150 Index Fund | Index Funds | 0.26% | ₹3.22Cr | ₹1,239Cr |
| ICICI Prudential QUANT FUND | Sectoral/ Thematic | 1.83% | ₹2.98Cr | ₹163.32Cr |
Weights come from each fund’s most recent disclosed portfolio, which SEBI requires monthly — positions can have changed since. “Position” is the weight applied to the scheme’s AUM, available for 127 of the 135 holders. Nothing here is advice, and a stock being widely held is not an argument for owning it.
Funds buying and selling GlaxoSmithKline Pharmaceuticals Limited
In their latest monthly disclosure, 10 funds bought and 12 sold, judged by share count.
Frequently asked questions
Which mutual fund holds the most GlaxoSmithKline Pharmaceuticals Limited?
By rupee value, SBI Midcap Fund from SBI — ₹320.25Cr, at 1.3% of that scheme's portfolio. Weights come from each fund's most recent disclosed portfolio; SEBI requires monthly disclosure, so a fund that has traded since its last filing may hold more or less than this.
Which fund has the highest weight in GlaxoSmithKline Pharmaceuticals Limited?
quant Healthcare Fund carries the largest weight at 8.9% of its portfolio. That is a different question from the largest rupee position — a small fund can hold a much bigger share of itself in one stock than a large fund does.
How many mutual funds hold GlaxoSmithKline Pharmaceuticals Limited?
135 schemes, holding ₹2,571Cr between them across the 127 whose AUM is on record. One row per scheme: a fund's Direct and Regular plans hold the same portfolio, so the Direct plan stands for both rather than counting twice.
Does a fund holding GlaxoSmithKline Pharmaceuticals Limited make it a good investment?
No. This page reports what funds disclosed they own, not a view on the stock or on any scheme holding it. A widely held stock is a popular one, which is a fact about other people's positions rather than about future returns. Nothing here is investment advice.